Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
24 pending office actions • 13 art units • 23 examiners • 0 of 24 (0%) have an AI response strategy ready • 14 patents granted in the last 365 days
Bayer HealthCare LLC is managing 23 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are assigned to 23 distinct examiners, meaning each examiner is responsible for a pending matter. WILLIAMS, TERESA S is the busiest examiner, holding 1 pending office action.
The 23 pending office actions are spread across 13 distinct art units. This distribution shows that while the examiners are entirely distinct, the technical focus is more concentrated within those 13 art units. Because there are 23 distinct examiners for the actions, the company faces a variety of individual examiner styles. WILLIAMS, TERESA S manages 1 of the total pending actions, which indicates that no single examiner has a dominant role in the current prosecution of the portfolio.
Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (12%) |
| §103 only | 4 (17%) |
| §112 only | 1 (4%) |
| Double-patenting only | 3 (12%) |
| Double-patenting + other | 2 (8%) |
| Multi-statute (no §101) | 11 (46%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PAZ ESTEVEZ, GUILLERMO G | 2 | 21.4% | +5.0% |
| WILLIAMS, TERESA S | 1 | 25.1% | +17.4% |
| ELSHAER, ALAAELDIN M | 1 | 36.1% | +30.5% |
| RAMIREZ, DELIA M | 1 | 65.1% | +56.3% |
| HAGOPIAN, CASEY SHEA | 1 | 54.4% | +33.3% |
| THIRUGNANAM, GANDHI | 1 | 73.4% | +13.3% |
| IMPINK, MOLLIE LLEWELLYN | 1 | 55.4% | +24.7% |
| ALLEN, ANDRE J | 1 | 91.4% | +6.4% |
| DARB, HAMZA A. | 1 | 74.4% | +30.9% |
| HUDSON, AMY ROSE | 1 | 74.9% | +11.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18813904 | SYSTEM AND METHOD FOR FLUID DELIVERY USING PRESSURE-BASED MOTOR CONTROL FOR FLUID INJECTOR DEVICES | ALLEN, ANDRE J | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19252857 | SYSTEM, METHOD AND DEVICE FOR DELIVERY OF A THERAPEUTIC OR DIAGNOSTIC AGENT | PAZ ESTEVEZ, GUILLERMO G | 78d overdue |
| 18453364 | MULTI-USE DISPOSABLE SYSTEM AND SYRINGE THEREFOR | SCHMIDT, EMILY LOUISE | 14d |
| 18263899 | METHODS OF ADJUSTING THE PH OF A CELL CULTURE MEDIUM | DUNN, MCKENZIE A | 26d |
| 19109553 | Systems and Methods for Generating Protocols Embodying Contrast and Radiation Dose Management Techniques | ELSHAER, ALAAELDIN M | 35d |
| 19481816 | SYSTEM, METHOD, AND COMPUTER PROGRAM PRODUCT FOR PLATFORM FOR DEVELOPMENT AND DEPLOYMENT OF ARTIFICIAL INTELLIGENCE BASED SOFTWARE AS MEDICAL DEVICE | WILLIAMS, TERESA S | — |
| 19016469 | NOVEL RNA-PROGRAMMABLE ENDONUCLEASE SYSTEMS AND USES THEREOF | RAMIREZ, DELIA M | — |
| 18859536 | Systems, Method, And Computer Program Product For Associating Injector And Imager Protocols | THIRUGNANAM, GANDHI | — |
| 18848564 | CHILD-PROOF STICK PACK | IMPINK, MOLLIE LLEWELLYN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19109553 | Systems and Methods for Generating Protocols Embodying Contrast and Radiation Dose Management Techniques | ELSHAER, ALAAELDIN M | 35d |
| 19481816 | SYSTEM, METHOD, AND COMPUTER PROGRAM PRODUCT FOR PLATFORM FOR DEVELOPMENT AND DEPLOYMENT OF ARTIFICIAL INTELLIGENCE BASED SOFTWARE AS MEDICAL DEVICE | WILLIAMS, TERESA S | — |
| 19016469 | NOVEL RNA-PROGRAMMABLE ENDONUCLEASE SYSTEMS AND USES THEREOF | RAMIREZ, DELIA M | — |
| 18875229 | NAPROXEN SODIUM TABLETS PRODUCED USING A CONTINUOUS PROCESS | HAGOPIAN, CASEY SHEA | — |
| 18859536 | Systems, Method, And Computer Program Product For Associating Injector And Imager Protocols | THIRUGNANAM, GANDHI | — |
| 18848564 | CHILD-PROOF STICK PACK | IMPINK, MOLLIE LLEWELLYN | — |
| 18720705 | AMMONIUM SULFATE TREATED SYRINGE FOR INCREASED PHARMACEUTICAL COMPOSITION STABILITY | DARB, HAMZA A. | — |
| 18671569 | GENE EDITING FOR HEMOPHILIA A WITH IMPROVED FACTOR VIII EXPRESSION | HUDSON, AMY ROSE | — |
| Art Unit | Apps |
|---|---|
| 3783 | 6 |
| 3687 | 2 |
| 1652 | 1 |
| 3799 | 1 |
| 1619 | 1 |
| 1611 | 1 |
| 1678 | 1 |
| 1658 | 1 |
| 1645 | 1 |
| 1683 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19481816 | SYSTEM, METHOD, AND COMPUTER PROGRAM PRODUCT FOR PLATFORM FOR DEVELOPMENT AND DEPLOYMENT OF ARTIFICIAL INTELLIGENCE BASED SOFTWARE AS MEDICAL DEVICE | WILLIAMS, TERESA S | 3687 | §101§102§103 | Non-Final OA | — | Pending | Nov 05, 2025 |
| 19252857 | SYSTEM, METHOD AND DEVICE FOR DELIVERY OF A THERAPEUTIC OR DIAGNOSTIC AGENT | PAZ ESTEVEZ, GUILLERMO G | 3783 | §103§112 | Final Rejection | 78d overdue | Pending | Jun 27, 2025 |
| 19109553 | Systems and Methods for Generating Protocols Embodying Contrast and Radiation Dose Management Techniques | ELSHAER, ALAAELDIN M | 3687 | §101§103 | Final Rejection | 35d | Pending | Mar 06, 2025 |
| 19016469 | NOVEL RNA-PROGRAMMABLE ENDONUCLEASE SYSTEMS AND USES THEREOF | RAMIREZ, DELIA M | 1652 | §102§103 | Non-Final OA | — | Pending | Jan 10, 2025 |
| 18875229 | NAPROXEN SODIUM TABLETS PRODUCED USING A CONTINUOUS PROCESS | HAGOPIAN, CASEY SHEA | — | §103DP | Non-Final OA | — | Pending | Dec 16, 2024 |
| 18859536 | Systems, Method, And Computer Program Product For Associating Injector And Imager Protocols | THIRUGNANAM, GANDHI | — | §101§102§112 | Non-Final OA | — | Pending | Oct 23, 2024 |
| 18848564 | CHILD-PROOF STICK PACK | IMPINK, MOLLIE LLEWELLYN | 3799 | §103§112 | Final Rejection | — | Pending | Sep 19, 2024 |
| 18813904 | SYSTEM AND METHOD FOR FLUID DELIVERY USING PRESSURE-BASED MOTOR CONTROL FOR FLUID INJECTOR DEVICES | ALLEN, ANDRE J | — | DP | Non-Final OA | — | Pending | Aug 23, 2024 |
| 18720705 | AMMONIUM SULFATE TREATED SYRINGE FOR INCREASED PHARMACEUTICAL COMPOSITION STABILITY | DARB, HAMZA A. | — | §102§103§112 | Non-Final OA | — | Pending | Jun 17, 2024 |
| 18671569 | GENE EDITING FOR HEMOPHILIA A WITH IMPROVED FACTOR VIII EXPRESSION | HUDSON, AMY ROSE | — | §103§112 | Non-Final OA | — | Pending | May 22, 2024 |
| 18646969 | Syringe Plunger With Dynamic Seal | ABU-DAYEH, TAGWA MOHAMMAD | 3783 | §102§103§112 | Non-Final OA | — | Pending | Apr 26, 2024 |
| 18421298 | HIGH CONCENTRATION SUSPENSION FORMULATION FOR COLD AND FLU SOFT GEL CAPSULE MEDICATIONS | PROSSER, ALISSA J | 1619 | §103 | Final Rejection | 12d | Pending | Jan 24, 2024 |
| 18392417 | CHEWABLE GEL PRODUCTS FOR ACTIVE PHARMACEUTICAL INGREDIENTS | GHALI, ISIS A D | 1611 | §103§112Other | Non-Final OA | — | Pending | Dec 21, 2023 |
| 18453364 | MULTI-USE DISPOSABLE SYSTEM AND SYRINGE THEREFOR | SCHMIDT, EMILY LOUISE | 3783 | §103§112 | Final Rejection | 14d | Pending | Aug 22, 2023 |
| 18546806 | AIR DETECTION AND MEASUREMENT SYSTEM FOR FLUID INJECTOR | TURKOWSKI, KAYLA MARIE | 3783 | §103§112 | Non-Final OA | — | Pending | Aug 17, 2023 |
| 18263899 | METHODS OF ADJUSTING THE PH OF A CELL CULTURE MEDIUM | DUNN, MCKENZIE A | 1678 | §102§103§112 | Non-Final OA | 26d | Pending | Aug 02, 2023 |
| 18121499 | Extended, High Dose VEGF Antagonist Regimens for Treatment of Angiogenic Eye Disorders | KATAKAM, SUDHAKAR | 1658 | DP | Non-Final OA | 9d overdue | Pending | Mar 14, 2023 |
| 18121490 | Extended, High Dose VEGF Antagonist Regimens for Treatment of Angiogenic Eye Disorders | SAOUD, CHRISTINE J | 1645 | DP | Non-Final OA | — | Pending | Mar 14, 2023 |
| 17776822 | METHODS OF SYNTHESIZING RNA MOLECULES | KAPUSHOC, STEPHEN THOMAS | 1683 | §103DP | Final Rejection | 35d overdue | Pending | May 13, 2022 |
| 17770696 | SYSTEM, METHOD, AND COMPUTER PROGRAM PRODUCT FOR SMART FLUID INJECTOR PERFORMANCE MONITORING | PAZ ESTEVEZ, GUILLERMO G | 3783 | §103 | Non-Final OA | — | Pending | Apr 21, 2022 |
| 17286276 | COMPOSITIONS AND METHODS FOR DELIVERING TRANSGENES | EBBINGHAUS, BRIANA NOEL | 1632 | §103§112Other | Final Rejection | — | Pending | Apr 16, 2021 |
| 17284947 | Softgels with solid or gel-like polymeric fill matrix | TCHERKASSKAYA, OLGA V | 1615 | §112 | Final Rejection | 26d | Pending | Apr 13, 2021 |
| 17270102 | Utilizing Pressure Measurements to Detect Reuse of Patient Lines | DEUTSCH, TAYLOR M | 3798 | §103 | Non-Final OA | — | Pending | Feb 22, 2021 |
| 17106697 | FLUID INJECTION SYSTEM HAVING VARIOUS SYSTEMS FOR CONTROLLING AN INJECTION PROCEDURE | ZAMORY, JUSTIN L | 3783 | §103 | Non-Final OA | 53d overdue | Pending | Nov 30, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial